The effect of antiestrogens on the nuclear binding of the estrogen receptor.
D000818:Animals; D000840:Anisoles / Q000494:pharmacology; D002467:Cell Nucleus / Q000378:metabolism*; D002996:Clomiphene / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D004048:Diethylamines / Q000494:pharmacology; D004958:Estradiol / Q000378:metabolism; D004965:Estrogen Antagonists; D000431:Ethanol / Q000031:analogs & derivatives / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D007536:Isomerism; D009256:Nafoxidine / Q000494:pharmacology*; D010647:Phenyl Ethers / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects*; D013343:Styrenes / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium; D014599:Uterus / Q000166:cytology
D000840:Anisoles; D004048:Diethylamines; D004965:Estrogen Antagonists; D010647:Phenyl Ethers; D011759:Pyrrolidines; D011956:Receptors, Cell Surface; D013343:Styrenes; D014316:Tritium; D002996:Clomiphene; D000431:Ethanol; D009256:Nafoxidine; D004958:Estradiol